A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW; International Natalizumab Multiple Sclerosis Trial Group.
Miller DH, et al. Among authors: miszkiel ka.
N Engl J Med. 2003 Jan 2;348(1):15-23. doi: 10.1056/NEJMoa020696.
N Engl J Med. 2003.
PMID: 12510038
Free article.
Clinical Trial.